Sign in

Perspectum Ltd

@perspectumltd.bsky.social
49 followers 16 following 229 posts

Perspectum® | Innovating medical imaging in Oxford - where tradition meets technology. AI-driven, patient-focused, advancing healthcare.

PostsRepliesMedia
Perspectum Ltd @perspectumltd.bsky.social · 13/10/2026
In 72 pediatric autoimmune liver disease patients, plasma bile acids tracked with quantitative MRCP+ measures of bile duct dilation. Routine labs did not. Cincinnati Children's poster P6273, Tue Oct 13, 10:30–4:00 CT, presented by Thuy Nguyen. #Perspectum #ACG2026
000 0
Perspectum Ltd @perspectumltd.bsky.social · 13/10/2026
Perspectum is at ASN #KidneyWk 2026 in Denver, 21–25 Oct. Caitlin Langford, Senior Director of Product, is meeting pharma and research teams to discuss quantitative MRI in renal drug development. Working on kidney trials? Come and find us. #Perspectum #Nephrology
000 0
Perspectum Ltd @perspectumltd.bsky.social · 12/10/2026
Alone, cT1, liver fat and spleen volume identified cirrhosis in MASLD with AUC 0.66 to 0.72. Combined: 0.87 (test cohort 0.85). Michele Pansini presents this poster at the Society for Advanced Body Imaging 2026, 13th October. Find him there or at our tabletop. #Perspectum #MASLD
000 0
Perspectum Ltd @perspectumltd.bsky.social · 08/10/2026
Perspectum is at @myueg.bsky.social Week 2026 in Barcelona, 17 to 20 October, with Marija Mavar, Reema Kainth, Nicholas Hyde and Dylan Windell. Working in IBD trials or GI pathology? Come and find us. #Perspectum #UEGWeek #IBD
000 0
Perspectum Ltd @perspectumltd.bsky.social · 06/10/2026
Metabolic disease rarely affects only one organ. So how do you capture a therapy's effects beyond its target organ in trial design? Thursday 15 October, #ELRIGDD26: Anna Veprik presents how multi-organ MR imaging can be used as a precision biomarker in drug discovery. #Perspectum #DrugDiscovery
000 0
Perspectum Ltd @perspectumltd.bsky.social · 05/10/2026
"Objective, reproducible measurements we can follow over time." That's how Dr Steven Tucker of Tucker Medical, describes Perspectum's quantitative MRI. perspectum.com/tucker-medical-integ…
000 0
Perspectum Ltd @perspectumltd.bsky.social · 05/10/2026
Perspectum is a Bronze Sponsor at SABI 2026, 11 to 14 Oct, Savannah GA. Michele Pansini and Balaji Ganeshan will be at our tabletop in the exhibit area to talk quantitative liver MRI and where it fits in body imaging workflows. Come and say hello. #Perspectum #SABI2026
000 0
Perspectum Ltd @perspectumltd.bsky.social · 02/10/2026
Heading to #ACG2026 in Nashville, Oct 9–14? Thuy Nguyen, VP US Medical Affairs and Prashant Pandya, Medical Director, are there all week to talk quantitative MRI in liver disease.
000 0
Perspectum Ltd @perspectumltd.bsky.social · 30/09/2026
Best Poster at the 12th Paris MASH Meeting went to our digital pathology team. In biopsy slides from 156 people with MASLD or MASH, PAIR™ MASH measurements agreed with expert pathologists, most strongly for fibrosis (rho 0.78). Congratulations, Dylan Windell and co-authors. #Perspectum #MASH
001 0
Perspectum Ltd @perspectumltd.bsky.social · 29/09/2026
Cardiovascular disease rarely occurs on its own. It develops alongside diabetes, obesity, high blood pressure and liver fat that accumulates silently for years. This World Heart Day, look at the whole system, not one organ. #Perspectum #WorldHeartDay
000 0
Perspectum Ltd @perspectumltd.bsky.social · 29/09/2026
The fat your BMI does not show. In 75,331 UK Biobank participants, people with more visceral fat on MRI were more likely to develop type 2 diabetes, independent of BMI. A single L3 slice showed a similar association to the whole-abdomen measurement. Presented at EASD 2026, Tue 30 Sep, 11:45 CEST.
000 0
Perspectum Ltd @perspectumltd.bsky.social · 29/09/2026
Heading to GHAPP in Chula Vista, 1 to 3 October? So are we. Perspectum is a Bronze Sponsor, and Dr Prashant Pandya and Jill Rizer will be there all three days. NPs and PAs in GI or hepatology: come and talk MRI-based liver assessment. #Perspectum #GHAPP2026
000 0
Perspectum Ltd @perspectumltd.bsky.social · 24/09/2026
Two patients can lose the same amount of weight and end up in very different physiological states. One loses visceral and ectopic fat. The other loses skeletal muscle. We integrate MRI body composition into obesity and cardiometabolic trials to characterise the quality of weight loss. #Perspectum
010 0
Perspectum Ltd @perspectumltd.bsky.social · 15/09/2026
Perspectum has appointed Warren Cresswell as Chief Executive Officer, effective 15 September 2026. He brings more than 25 years in life sciences, much of it leading diagnostics businesses. Read the announcement: pulse.ly/s5lyx0rcwg #Perspectum
011 0
Perspectum Ltd @perspectumltd.bsky.social · 14/09/2026
We're proud to announce that Principal Cardiovascular Scientist Masliza Mahmod, was awarded Fellow of the European Society of Cardiology in Munich, pictured with ESC Vice President Prof Marco Roffi. Congratulations, Masliza! #Perspectum #ESCCongress
010 0
Perspectum Ltd @perspectumltd.bsky.social · 11/09/2026
One non-contrast MRI, a fuller picture of liver health. In 769 people under HCC surveillance in Singapore, qMRI found steatotic liver disease in over 40% with hepatitis B and identified cirrhosis in MASLD (AUC 0.88). bmcgastroenterol.biomedcentral.com/…
000 0
Perspectum Ltd @perspectumltd.bsky.social · 10/09/2026
Three posters at the 12th Paris MASH Meeting, Institut Pasteur, 10–11 September. Alcohol exposure and liver iron. Where fat sits in cirrhosis. Continuous histology measurements against expert scoring. Presented by Andrea Dennis, 10 September. #Perspectum #MASH
000 0
Perspectum Ltd @perspectumltd.bsky.social · 10/09/2026
Perspectum is a Gold Sponsor of the 2026 Frontiers in Gastroenterology: Conference for Nurses and Healthcare Professionals. See you in Los Angeles! #Perspectum #LiverMultiScan #Gastroenterology #Hepatology #GINursing #LiverHealth
000 0
Perspectum Ltd @perspectumltd.bsky.social · 09/09/2026
Perspectum will be at RAPS Convergence 2026 in Charlotte, North Carolina, from 15 to 17 September. Bhaskar Chikkanna, our Director of Quality Assurance and Regulatory Affairs, will be joining three days of sessions from across the global community. #Perspectum #RAPSConvergence
030 0
Perspectum Ltd @perspectumltd.bsky.social · 08/09/2026
We're at the 12th Paris MASH Meeting, 10–11 Sept. PAIR™ MASH: AI designed for quantitative, reproducible histology assessment in late-phase trials. perspectum.com/pharma/masld-mash-ci… #Perspectum #MASH
000 0
Perspectum Ltd @perspectumltd.bsky.social · 28/08/2026
Perspectum is a Bronze sponsor of the 31st Annual Scientific Meeting of the British and Irish Chapter of the ISMRM, 2 to 4 September at Bush House, Strand Campus, King's College London. Meet our attending team! perspectum.com #Perspectum #BICISMRM
010 0
Perspectum Ltd @perspectumltd.bsky.social · 28/08/2026
Three questions about one liver: fat, damage, activity. LiverMultiScan answers two in one ~5 min non-contrast MRI. cT1 for disease activity, PDFF for fat, LIC too. Fibrosis is what has accumulated. cT1 is what is happening now. perspectum.com/products/livermultis… #Perspectum #MASLD
010 0
Perspectum Ltd @perspectumltd.bsky.social · 24/08/2026
A treatment effect can be real yet go undetected. Trial endpoints from different vendors, scanners and standards each add variance that masks it. Perspectum is at ESC Congress, Munich, 28–31 Aug, to discuss quantitative MRI standardized across scanners, sites and readers. #Perspectum #ESCCongress
021 0
Perspectum Ltd @perspectumltd.bsky.social · 18/08/2026
Most health checks look at organs one by one. Chronic conditions don't work that way. We're partnering with SAM's Advanced Medicine Imaging to bring CoverScan to patients in Singapore! perspectum.com/singapore-institute-… #Perspectum
010 0
Perspectum Ltd @perspectumltd.bsky.social · 14/08/2026
Cirrhosis still drives prognosis and management. But F4 is one category, not one biological state: two people at the same stage can differ in ongoing injury and remodeling. How do we assess both structure and activity? #Perspectum #Hepatology #LiverDisease #Cirrhosis
000 0
Perspectum Ltd @perspectumltd.bsky.social · 12/08/2026
Is disease activity elevated despite low liver stiffness? In a real-world cohort, low fibrosis risk by MRE (<3.14 kPa) with elevated cT1 (>800 ms) carried a higher risk of biochemical worsening over approximately 12 months than other MRE/cT1 groups (HR 3.1). #Perspectum #cT1
000 0
Perspectum Ltd @perspectumltd.bsky.social · 10/08/2026
BALANCE has recruited its first UK patient. Oxford CTRU will use CoverScan to quantify liver disease activity, and measures of fat, structure and function in other organs, at baseline and at six months. www.ouh.nhs.uk/news/articles/2452 #Perspectum #Rheumatology
011 0
Perspectum Ltd @perspectumltd.bsky.social · 04/08/2026
An imaging endpoint you can't reproduce isn't really an endpoint. perspectum.com/wp-content/uploads/2… #Perspectum #CardiovascularResearch #ClinicalTrials #CardiacMRI #MedicalImaging
111 0
Perspectum Ltd @perspectumltd.bsky.social · 30/07/2026
One fibrosis stage can coexist with varying disease activity. The starting question is not which test to run, but what to measure. MRI-PDFF: liver fat. Fibrosis: accumulated damage. cT1: disease activity now, and change over time. perspectum.com/products/livermultiscan #Perspectum #MASLD
000 0
Perspectum Ltd @perspectumltd.bsky.social · 21/07/2026
Two patients, similar fibrosis stage, different disease activity. Fibrosis = structural burden. MRI-PDFF = fat. cT1 = disease activity. Together, a fuller picture of MASLD & how it changes on treatment. perspectum.com/products/livermultis… #MASLD #MASH
000 0
Perspectum Ltd @perspectumltd.bsky.social · 15/07/2026
Not all body fat carries the same risk, and the dangerous kind doesn't show up on the scales. MRI-measured visceral fat predicted type 2 diabetes, liver, cardiovascular and kidney events beyond BMI. And one MRI slice matched a full abdominal 3D scan. #Perspectum #ICO2026
000 0
Perspectum Ltd @perspectumltd.bsky.social · 15/07/2026
Standard checks can miss liver disease in children. Imaging can reveal it. In Mexico's METCOG cohort, ~1 in 7 children scanned showed signs of MASLD, often without symptoms. Observational study. Luis presents at ICO 2026: icocongress.com/programme-overview #Perspectum #ICO2026 #MASLD
000 0
Perspectum Ltd @perspectumltd.bsky.social · 15/07/2026
159 vs 20. The estimated number you'd treat with a weight-loss medication to delay one death, before and after adding two MRI measurements to the decision. 23,087 UK Biobank participants. Modeled on published trial data. Our ICO 2026 poster. #Perspectum #ICO2026
001 0
Perspectum Ltd @perspectumltd.bsky.social · 12/07/2026
Seeing and measuring iron in the brain is hard. At AAIC today, our poster shows QSM can be successfully implemented in superficial siderosis, giving improved visualisation and contrast of hemosiderin (iron) deposition vs R2* and SWI. Early cohort data are encouraging. #Perspectum #AAIC2026
000 0
Perspectum Ltd @perspectumltd.bsky.social · 10/07/2026
Beyond the scale: in one scan, multi-organ MRI measures fat, muscle and organ health. Meet our Pharma team, Marine and Khant, at the Obesity & Weight Loss Drug Development Summit. Boston, Jul 14–16. #Perspectum #ObesitySummit #MultiOrganMRI
000 0
Perspectum Ltd @perspectumltd.bsky.social · 08/07/2026
We're heading to Mexico City. Perspectum is at the International Congress on Obesity! BMI alone doesn't tell you where the risk sits. The liver, heart, pancreas and muscle do. We'll be sharing new quantitative MRI research on sharpening risk stratification in obesity. #Perspectum #ICO2026
000 0
Perspectum Ltd @perspectumltd.bsky.social · 08/07/2026
Iron leaves a trace in the brain, and measuring it precisely is hard. Quantitative Susceptibility Mapping (QSM) gives a quantitative view of iron accumulation from MRI. We're bringing this work to AAIC in London, July 12–15. Come find us. #Perspectum #AAIC2026 #Neuroimaging
000 0
Perspectum Ltd @perspectumltd.bsky.social · 02/07/2026
New in JHEP Reports: The new qmAOM score combines quantitative MRCP with the Amsterdam Oxford model, and outperforms currently used scores in the prediction of long-term, event-free survival in patients with PSC. 📄 www.jhep-reports.eu/article/S2589-5… #Perspectum
000 0
Perspectum Ltd @perspectumltd.bsky.social · 25/06/2026
This Armed Forces Week, we're proud to recognise the veterans and reservists across our team, and to reaffirm our commitment as a signatory of the Armed Forces Covenant. #Perspectum #ArmedForcesWeek #ArmedForcesCovenant
000 0
Perspectum Ltd @perspectumltd.bsky.social · 22/06/2026
At the SOLAR Conference 2026, our Senior Medical Director, Carlos Duncker, will co-present "Updates on Promising NITs (ProC3, cT1, MASEF score)" in Session 4: NITs and Trials Design. Friday June 26, 2:20pm. #Perspectum #MASH
000 0
Perspectum Ltd @perspectumltd.bsky.social · 18/06/2026
We’re heading to SOLAR Conference 2026, where MASH, NITs, biomarkers, & trial design are major themes across the program. We will be there discussing how quantitative MRI & imaging biomarkers can support patient selection, endpoint strategies, & treatment monitoring in MASH trials. #Perspectum
000 0
Perspectum Ltd @perspectumltd.bsky.social · 16/06/2026
MASLD tests mostly measure accumulated injury, damage already done. But clinicians need to know what's happening now: Is disease active? Progressing? Responding? That mismatch is why similar data leads to different decisions. Find out more: perspectum.com/clinical-solutions #Perspectum
000 0
Perspectum Ltd @perspectumltd.bsky.social · 11/06/2026
By 2030, 357 million people will be living with fatty liver disease, most without knowing it. This Global Fatty Liver Day, we're confronting one of the world's most overlooked health crises. Detected early, liver disease is more manageable. Awareness drives action. #Perspectum #GlobalFattyLiverDay
000 0
Perspectum Ltd @perspectumltd.bsky.social · 09/06/2026
Obesity care has changed faster than how we measure it. BMI & the scale miss what's actually happening inside the body. Perspectum's Medical Lead Krishan Bountra is at the Economist Impact Obesity & Metabolic Health Summit, talking contrast-free MRI body composition. #Perspectum
110 0
Perspectum Ltd @perspectumltd.bsky.social · 08/06/2026
As presented at ADA Scientific Sessions 2026! Read the full press release: www.boehringer-ingelheim.com/human-… #Perspectum #ADA2026 #BoehringerIngelheim
000 0
Perspectum Ltd @perspectumltd.bsky.social · 05/06/2026
The scale is moving for more patients than ever, but cardiometabolic risk doesn't always move with it. 📍 Monday 8 June, 12:30–1:30 PM CDT. Poster Hall, Halls D‑E. #Perspectum #ADA2026 #ADAScientificSessions
000 0
Perspectum Ltd @perspectumltd.bsky.social · 04/06/2026
The next chapter of obesity care isn't being written on by scale. It's being written with body composition. Perspectum heads to ADA Scientific Sessions, 5–8 June, New Orleans, to talk precision imaging in body comp across obesity research and care. #Perspectum #ADA2026 #Obesity
000 0
Perspectum Ltd @perspectumltd.bsky.social · 28/05/2026
Two posters. One question driving both: how do we see what is happening inside the liver, earlier and with more confidence? Coming to EASL? We would value your read on the data. Stop by, ask the hard questions. perspectum.com #Perspectum #EASLCongress
000 0
Perspectum Ltd @perspectumltd.bsky.social · 27/05/2026
EASL Congress 2026. Barcelona. 27–30 May. 8,000 hepatologists, one focus: catching liver disease earlier. Perspectum is on the ground with new evidence on quantitative imaging and AI in chronic liver disease. #Perspectum #EASLCongress #Hepatology #MASH
000 0
Perspectum Ltd @perspectumltd.bsky.social · 22/05/2026
One in three adults worldwide is now living with steatotic liver disease, and most don't know it yet. That's the scale of the challenge driving the Global Think-tank on Steatotic Liver Disease. We'd love to connect! 📧https://t8glx.share.hsforms.com/2pZ-uQnvBQ562gUAkYToz9Q #Perspectum
000 0